162 related articles for article (PubMed ID: 15590640)
1. Regulation of complement C3 expression by the bile acid receptor FXR.
Li J; Pircher PC; Schulman IG; Westin SK
J Biol Chem; 2005 Mar; 280(9):7427-34. PubMed ID: 15590640
[TBL] [Abstract][Full Text] [Related]
2. Farnesoid X receptor regulates bile acid-amino acid conjugation.
Pircher PC; Kitto JL; Petrowski ML; Tangirala RK; Bischoff ED; Schulman IG; Westin SK
J Biol Chem; 2003 Jul; 278(30):27703-11. PubMed ID: 12754200
[TBL] [Abstract][Full Text] [Related]
3. The farnesoid X-activated receptor mediates bile acid activation of phospholipid transfer protein gene expression.
Urizar NL; Dowhan DH; Moore DD
J Biol Chem; 2000 Dec; 275(50):39313-7. PubMed ID: 10998425
[TBL] [Abstract][Full Text] [Related]
4. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor.
Pineda Torra I; Claudel T; Duval C; Kosykh V; Fruchart JC; Staels B
Mol Endocrinol; 2003 Feb; 17(2):259-72. PubMed ID: 12554753
[TBL] [Abstract][Full Text] [Related]
5. Identification of DRIP205 as a coactivator for the Farnesoid X receptor.
Pineda Torra I; Freedman LP; Garabedian MJ
J Biol Chem; 2004 Aug; 279(35):36184-91. PubMed ID: 15187081
[TBL] [Abstract][Full Text] [Related]
6. Coordinated control of bile acids and lipogenesis through FXR-dependent regulation of fatty acid synthase.
Matsukuma KE; Bennett MK; Huang J; Wang L; Gil G; Osborne TF
J Lipid Res; 2006 Dec; 47(12):2754-61. PubMed ID: 16957179
[TBL] [Abstract][Full Text] [Related]
7. FXR regulates organic solute transporters alpha and beta in the adrenal gland, kidney, and intestine.
Lee H; Zhang Y; Lee FY; Nelson SF; Gonzalez FJ; Edwards PA
J Lipid Res; 2006 Jan; 47(1):201-14. PubMed ID: 16251721
[TBL] [Abstract][Full Text] [Related]
8. Regulation of carbohydrate metabolism by the farnesoid X receptor.
Stayrook KR; Bramlett KS; Savkur RS; Ficorilli J; Cook T; Christe ME; Michael LF; Burris TP
Endocrinology; 2005 Mar; 146(3):984-91. PubMed ID: 15564327
[TBL] [Abstract][Full Text] [Related]
9. Farnesoid X receptor represses hepatic lipase gene expression.
Sirvent A; Verhoeven AJ; Jansen H; Kosykh V; Darteil RJ; Hum DW; Fruchart JC; Staels B
J Lipid Res; 2004 Nov; 45(11):2110-5. PubMed ID: 15342685
[TBL] [Abstract][Full Text] [Related]
10. Coordinated control of cholesterol catabolism to bile acids and of gluconeogenesis via a novel mechanism of transcription regulation linked to the fasted-to-fed cycle.
De Fabiani E; Mitro N; Gilardi F; Caruso D; Galli G; Crestani M
J Biol Chem; 2003 Oct; 278(40):39124-32. PubMed ID: 12865425
[TBL] [Abstract][Full Text] [Related]
11. Farnesoid X-activated receptor induces apolipoprotein C-II transcription: a molecular mechanism linking plasma triglyceride levels to bile acids.
Kast HR; Nguyen CM; Sinal CJ; Jones SA; Laffitte BA; Reue K; Gonzalez FJ; Willson TM; Edwards PA
Mol Endocrinol; 2001 Oct; 15(10):1720-8. PubMed ID: 11579204
[TBL] [Abstract][Full Text] [Related]
12. Mouse species-specific control of hepatocarcinogenesis and metabolism by FGF19/FGF15.
Zhou M; Luo J; Chen M; Yang H; Learned RM; DePaoli AM; Tian H; Ling L
J Hepatol; 2017 Jun; 66(6):1182-1192. PubMed ID: 28189755
[TBL] [Abstract][Full Text] [Related]
13. Ileal bile acid-binding protein, functionally associated with the farnesoid X receptor or the ileal bile acid transporter, regulates bile acid activity in the small intestine.
Nakahara M; Furuya N; Takagaki K; Sugaya T; Hirota K; Fukamizu A; Kanda T; Fujii H; Sato R
J Biol Chem; 2005 Dec; 280(51):42283-9. PubMed ID: 16230354
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of hepatic farnesoid X receptor by FGF19 signaling-activated Src maintains cholesterol levels and protects from atherosclerosis.
Byun S; Jung H; Chen J; Kim YC; Kim DH; Kong B; Guo G; Kemper B; Kemper JK
J Biol Chem; 2019 May; 294(22):8732-8744. PubMed ID: 30996006
[TBL] [Abstract][Full Text] [Related]
15. Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element.
Claudel T; Sturm E; Duez H; Torra IP; Sirvent A; Kosykh V; Fruchart JC; Dallongeville J; Hum DW; Kuipers F; Staels B
J Clin Invest; 2002 Apr; 109(7):961-71. PubMed ID: 11927623
[TBL] [Abstract][Full Text] [Related]
16. The cholesterol-raising factor from coffee beans, cafestol, as an agonist ligand for the farnesoid and pregnane X receptors.
Ricketts ML; Boekschoten MV; Kreeft AJ; Hooiveld GJ; Moen CJ; Müller M; Frants RR; Kasanmoentalib S; Post SM; Princen HM; Porter JG; Katan MB; Hofker MH; Moore DD
Mol Endocrinol; 2007 Jul; 21(7):1603-16. PubMed ID: 17456796
[TBL] [Abstract][Full Text] [Related]
17. Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression.
Claudel T; Inoue Y; Barbier O; Duran-Sandoval D; Kosykh V; Fruchart J; Fruchart JC; Gonzalez FJ; Staels B
Gastroenterology; 2003 Aug; 125(2):544-55. PubMed ID: 12891557
[TBL] [Abstract][Full Text] [Related]
18. Repression of farnesoid X receptor during the acute phase response.
Kim MS; Shigenaga J; Moser A; Feingold K; Grunfeld C
J Biol Chem; 2003 Mar; 278(11):8988-95. PubMed ID: 12519762
[TBL] [Abstract][Full Text] [Related]
19. Regulation of drug transporters by the farnesoid X receptor in mice.
Maeda T; Miyata M; Yotsumoto T; Kobayashi D; Nozawa T; Toyama K; Gonzalez FJ; Yamazoe Y; Tamai I
Mol Pharm; 2004; 1(4):281-9. PubMed ID: 15981587
[TBL] [Abstract][Full Text] [Related]
20. Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity.
Guo GL; Lambert G; Negishi M; Ward JM; Brewer HB; Kliewer SA; Gonzalez FJ; Sinal CJ
J Biol Chem; 2003 Nov; 278(46):45062-71. PubMed ID: 12923173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
